Farah D, Sturrock R D, Russell R I
Department of Gastroenterology, Royal Infirmary, Glasgow.
Ann Rheum Dis. 1988 Jun;47(6):478-80. doi: 10.1136/ard.47.6.478.
In a study of patients attending a rheumatology clinic 230 unselected patients, 185 with rheumatoid arthritis (RA) and 45 with other rheumatic disorders (non-RA), were examined by endoscopy and a detailed history of symptoms referable to the gastrointestinal tract was taken. A peptic ulcer was found in 67 (36%) of the patients and in 13 (29%) of the non-RA group. Gastric ulceration was more common in the group with RA (32 patients (17%) compared with three patients (7%) in the non-RA group); 17/32 (53%) patients with RA and gastric ulcer were asymptomatic. In the group with RA, of those with gastric ulcer 20/32 (63%) were smokers, compared with only 40/118 (34%) of the non-ulcer group. There was no difference in the duration of rheumatic disease or non-steroidal anti-inflammatory drug (NSAID) treatment between the ulcer and non-ulcer groups. Treatment with H2 receptor antagonist and maintenance of NSAID treatment resulted in healing in 26 out of 29 (90%) patients with gastric ulcer and 23 out of 27 (85%) patients with duodenal ulcer.
在一项针对风湿科门诊患者的研究中,对230名未经挑选的患者进行了检查,其中185名类风湿关节炎(RA)患者和45名其他风湿性疾病(非RA)患者接受了内镜检查,并详细记录了胃肠道相关症状的病史。67名(36%)患者发现有消化性溃疡,非RA组中有13名(29%)患者有消化性溃疡。胃溃疡在RA组中更为常见(32例患者(17%),而非RA组为3例患者(7%));17/32(53%)的RA合并胃溃疡患者无症状。在RA组中,患有胃溃疡的患者中有20/32(63%)是吸烟者,而非溃疡组中只有40/118(34%)是吸烟者。溃疡组和非溃疡组之间的风湿性疾病病程或非甾体抗炎药(NSAID)治疗时间没有差异。使用H2受体拮抗剂治疗并维持NSAID治疗后,29名胃溃疡患者中有26名(90%)愈合,27名十二指肠溃疡患者中有23名(85%)愈合。